Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

This is a single-arm study to investigate 1-year treatment related mortality (TRM) in patients with life threatening non-malignant and malignant hematologic disorders who do not have a matched related donor for allogeneic transplantation.

Trial Details

NCT ID
NCT04644016
Phase
PHASE2
Sponsor
Memorial Sloan Kettering Cancer Center
Status
RECRUITING
Cancer Type
Lymphoma
Interventions
  • Clofarabine
  • Fludarabine
  • Busulfan
  • Cyclosporine-A
  • Mycophenolate Mofetil
  • Cord Blood Graft
Locations (sample)
  • New York, New York, United States|40.71427,-74.00597

Key Eligibility Criteria

  • Age and Donor Status:
  • Patients with age ≤ 21 years at time of consent with no available and suitably matched related or unrelated donor in the required time period.
  • Diagnoses :
  • I. Acute myelogenous leukemia (AML) :

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lymphoma Trials on Trialify →